In line with ACR tips, allopurinol is strongly recommended as a first-line urate-reducing medication. Genetic screening is suggested (for your variant referred to as HLA B*5801) just before setting up allopurinol because the carriers of this gene are at an increased threat of the significant allergic response.Penyelidikan lanjutan sangat berkemungk